Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HTFL
HEARTFLOW, INC. COMMON STOCK
NASDAQ
$47.78
▼ DOWN 0.67% (-0.32)

KEY STATISTICS

Market Cap$4.12 B
52w High$51.19
52w Low$20.13
Dividend Yield—
Frequency—
P/E-23.77
Volume1.39M
Shares Out.86.24M

COMPANY

LEADERSHIP

John Farquhar
CHIEF EXECUTIVE
John Farquhar

COMPENSATION 2026

Salary$647,971
Stock Awards$1,137,492
Incentive Plan Pay$785,400
All Other Comp.$6,520
Total$5,989,882

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 7, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
843

PRICE TARGET

Target High$45.00
Target Low$37.00
Target Median$45.00
Target Consensus$42.83

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$65.27M
NOV
11
WED

PRICE

$47.78 ▼ DOWN 0.67% (−$0.32)
$47.50$48.00$48.50$49.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM47.78

About Heartflow, Inc. Common Stock

https://www.heartflow.com ↗

HeartFlow, Inc. develops AI-powered non-invasive solutions for diagnosing and managing coronary artery disease by creating personalized 3D heart models from CT scans to assess blood flow, stenosis, and plaque.

INDUSTRY

Medical - Healthcare Information Services

A PRODUCT HEARTFLOW, INC. COMMON STOCK IS KNOWN FOR

HeartFlow Plaque Analysis
HeartFlow Plaque Analysis

An AI-powered diagnostic tool that creates personalized 3D coronary artery models from CT scans to assess plaque and CAD risk, with the FDA-cleared 'Next Gen' version driving growth and expanding insurance coverage.

COMPETITORS

COMPETITOR
BSX COMPARE
GEHC COMPARE
IRTC COMPARE
OPCH COMPARE
RDNT COMPARE

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q1-2026Q2-2026
UNITED STATES$39.99M $42.95M ▲— —
NonUS— — $3.6M $3.77M ▲
JAPAN$1.53M $1.46M ▼— —
Rest Of Europe$348K $349K ▲— —

ETFS HOLDING THIS STOCK

ETFS HOLDING
117
LISTED HERE
22
RANKED BY POSITION SIZE
VTS.AX
0.00% · 2.5M
IWM
0.13% · 2.1M
R2SC.L
0.12% · 150.0K
XCHA.DE
0.27% · 113.2K
SCHA
0.02% · 84.2K
FBCG
0.04% · 63.4K
NUSC
0.14% · 41.3K
RSSL
0.12% · 38.4K
BBSC
0.14% · 21.3K
GOAI.MI
0.04% · 10.9K
GSSC
0.03% · 7.3K
AI
AIMS
0.32% · 6.0K
RFLR
0.23% · 4.7K
HLTH
2.69% · 4.3K
URTY
0.05% · 3.3K
TILT
0.01% · 3.2K
RTWP.L
0.05% · 2.4K
IQM
0.12% · 2.3K
MMSC
0.21% · 2.3K
ACSG
0.16% · 1.8K
USUE.DE
0.00% · 185
RTYS.L
0.12% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
238
TOP 12 OF 238 · RANKED BY POSITION SIZE
Xxec, Inc.
77.3M sh · $2.52M
Bain Capital Life Sciences Investors, LLC
12.4M sh · $362.86M
Wellington Management Group Llp
12.0M sh · $291.53M
Fmr LLC
5.4M sh · $131.33M
Blackrock, Inc.
5.2M sh · $152.5M
Bamco Inc /Ny/
3.8M sh · $93.12M
Baillie Gifford & Co
3.0M sh · $101.18M
Invesco Ltd.
2.3M sh · $67.44M
Janus Henderson Group Plc
2.2M sh · $53.06M
Schusterman Interests, LLC
1.9M sh · $56.53M
Alliancebernstein L.P.
1.9M sh · $46.82M
Point72 Asset Management, L.P.
1.7M sh · $50.5M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Farquhar John C.M.
Sale · 27.2K shares
2026-08-21
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Farquhar John C.M.
Sale · 32.7K shares
2026-08-18
★
OFFICER: CHIEF MEDICAL OFFICER
Rogers Campbell
Sale · 9.2K shares
2026-08-17
★
OFFICER: CHIEF MEDICAL OFFICER
Rogers Campbell
Purchase · 9.2K shares
2026-08-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 3
BUY 2
EQUAL WEIGHT 1
6 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY JP Morgan OVERWEIGHT Morgan Stanley EQUAL WEIGHT Piper Sandler OVERWEIGHT Stifel BUY Wells Fargo OVERWEIGHT

SECTORS PEERS

PEERPRICE
TVTX$65.67COMPARE
LIVN$80.32COMPARE
LEGN$19.88COMPARE
TARS$71.76COMPARE
IRON$80.03COMPARE
ZLAB$26.08COMPARE
PRVA$20.79COMPARE
PRGO$14.48COMPARE